Cargando…
Honokiol inhibits the growth of hormone-resistant breast cancer cells: its promising effect in combination with metformin
BACKGROUND AND PURPOSE: Primary and metastatic breast cancers still represent an unmet clinical need for improved chemotherapy and hormone therapy. Considerable attention has been paid to natural anticancer compounds, especially lignans. The study aimed to evaluate the activity of several lignans ag...
Autores principales: | Mikhaevich, Ekaterina I., Sorokin, Danila V., Scherbakov, Alexander M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568957/ https://www.ncbi.nlm.nih.gov/pubmed/37842518 http://dx.doi.org/10.4103/1735-5362.383712 |
Ejemplares similares
-
Targeting hormone-resistant breast cancer cells with docetaxel: a look inside the resistance
por: Scherbakov, Alexander M., et al.
Publicado: (2023) -
Exosomes are involved in the intercellular transfer of rapamycin resistance in the breast cancer cells
por: Shchegolev, Yuri Yu., et al.
Publicado: (2023) -
Towards Unravelling the Role of ERα-Targeting miRNAs in the Exosome-Mediated Transferring of the Hormone Resistance
por: Andreeva, Olga E., et al.
Publicado: (2021) -
Metformin Restores the Drug Sensitivity of MCF-7 Cells Resistant Derivates via the Cooperative Modulation of Growth and Apoptotic-Related Pathways
por: Sorokin, Danila, et al.
Publicado: (2020) -
Honokiol inhibits the growth of SKBR3 cells
por: Shi, He, et al.
Publicado: (2020)